TREATMENT OF FEVER AND NEUTROPENIA IN HEMATOLOGY/ONCOLOGY AND HEMATOPOIETIC CELL TRANSPLANT PATIENTS
![Neutropenic Fever: What Is It, Causes, Symptoms, Diagnosis, Risk Assessment, Treatment, Prevention, and More | Osmosis Neutropenic Fever: What Is It, Causes, Symptoms, Diagnosis, Risk Assessment, Treatment, Prevention, and More | Osmosis](https://d16qt3wv6xm098.cloudfront.net/GMUxah7HRrCJpA-WZlcNpFl3Ru62cNRA/_.png)
Neutropenic Fever: What Is It, Causes, Symptoms, Diagnosis, Risk Assessment, Treatment, Prevention, and More | Osmosis
![Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial - The Lancet Haematology Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial - The Lancet Haematology](https://www.thelancet.com/cms/attachment/16c8a49b-1cb2-4666-b666-22fdffcb5861/gr1.gif)
Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial - The Lancet Haematology
![Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper | SpringerLink Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00520-020-05906-y/MediaObjects/520_2020_5906_Fig1_HTML.png)
Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper | SpringerLink
![Continuous Temperature Monitoring for Earlier Fever Detection in Neutropenic Patients: Comparison with Standard of Care Continuous Temperature Monitoring for Earlier Fever Detection in Neutropenic Patients: Comparison with Standard of Care](https://temptraq.healthcare/wp-content/uploads/2022/07/TempTraq_logo.jpg)
Continuous Temperature Monitoring for Earlier Fever Detection in Neutropenic Patients: Comparison with Standard of Care
![Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study): A retrospective comparative cohort study - eClinicalMedicine Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study): A retrospective comparative cohort study - eClinicalMedicine](https://www.thelancet.com/cms/asset/c1664b3a-801a-4663-b216-0ed525683a57/gr1.jpg)
Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study): A retrospective comparative cohort study - eClinicalMedicine
![PDF) Continuous Temperature Monitoring for Earlier Fever Detection in Neutropenic Patients: Patient's Acceptance and Comparison with Standard of Care PDF) Continuous Temperature Monitoring for Earlier Fever Detection in Neutropenic Patients: Patient's Acceptance and Comparison with Standard of Care](https://www.researchgate.net/publication/323491000/figure/fig1/AS:868375811063818@1584048335766/Diagnostic-ability-of-TSP-was-assessed-against-SOC-The-TSP-between-each-SOC-measurements_Q320.jpg)
PDF) Continuous Temperature Monitoring for Earlier Fever Detection in Neutropenic Patients: Patient's Acceptance and Comparison with Standard of Care
![Managing Neutropenia in a Patient with Abdominal Pain Following Chemotherapy - Cancer Therapy Advisor Managing Neutropenia in a Patient with Abdominal Pain Following Chemotherapy - Cancer Therapy Advisor](https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2018/12/cta_tabletemp_tables415_348489.jpg)
Managing Neutropenia in a Patient with Abdominal Pain Following Chemotherapy - Cancer Therapy Advisor
![Blue Spark Technologies on Twitter: "#ICYMI: A recent @UMich study found that TempTraq detected fever earlier compared to a conventional thermometer in pediatric cancer patients at risk of febrile neutropenia. Read the Blue Spark Technologies on Twitter: "#ICYMI: A recent @UMich study found that TempTraq detected fever earlier compared to a conventional thermometer in pediatric cancer patients at risk of febrile neutropenia. Read the](https://pbs.twimg.com/media/FZVT8xoXgAA7bOk.jpg)
Blue Spark Technologies on Twitter: "#ICYMI: A recent @UMich study found that TempTraq detected fever earlier compared to a conventional thermometer in pediatric cancer patients at risk of febrile neutropenia. Read the
![A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia | Scientific Reports A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-11576-z/MediaObjects/41598_2022_11576_Fig1_HTML.png)